AI brief of an SEC Form 8-K · JBT Marel (JBTM)

JBT Marel reports record Q4 orders; 2025 guidance projects loss from continuing operations

Mixed Impact 4 of 5 guidance Written later

JBT Marel reported fourth quarter and full year 2024 results for JBT standalone, with fourth quarter loss from continuing operations of $7 million and full year income from continuing operations of $85 million, down $45 million, reflecting M&A costs and a pension settlement expense. The company also provided 2025 guidance projecting a loss from continuing operations of $70 million to $35 million, with adjusted EPS of $5.50 to $6.10, and raised its cost synergy target to $150 million.

Key points

  • Q4 2024 JBT standalone: record quarterly orders of $523 million; loss from continuing operations of $7 million versus income of $53 million a year earlier
  • Full year 2024 JBT standalone: revenue of $1,716 million, up 3 percent; adjusted EBITDA of $295 million, up 8 percent
  • 2025 guidance: revenue of $3,575 million to $3,650 million; loss from continuing operations of $70 million to $35 million; adjusted EPS of $5.50 to $6.10
  • Cost synergy expectation raised from $125 million to $150 million within three years after the January 2, 2025 combination with Marel

The filing

CompanyJBT Marel (JBTM)
Form8-K, current report
Filed with the SECFeb 24, 2025, 4:29 PM ET
Accession number0001433660-25-000002

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 12:58 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 24, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.